# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA2359093 | 2b, RB | IC50 | = | 8 | nM | ALA5150246 | 8.10 | nM | Vesicular stomatitis virus | ||
2. | ALA2359093 | 2b, RB | IC50 | = | 50 | nM | ALA5150245 | 7.30 | nM | Human immunodeficiency virus | ||
3. | ALA2359093 | 2b, RB | IC50 | = | 300 | nM | ALA5150244 | 6.52 | nM | unidentified influenza virus | ||
4. | ALA2359093 | 2b, RB | IC50 | = | 136 | uM | ALA5150243 | nM | ||||
5. | ALA2359093 | 2b, RB | IC50 | = | 75 | uM | ALA5150242 | 4.12 | nM | |||
6. | ALA2359093 | 2b, RB | IC50 | = | 73 | uM | ALA5150241 | 4.14 | nM | |||
7. | ALA2359093 | 2b, RB | IC50 | = | 51 | uM | ALA5150240 | 4.29 | nM | |||
8. | ALA2359093 | 2b, RB | IC50 | = | 75 | uM | ALA5150239 | 4.12 | nM | |||
9. | ALA2359093 | 2b, RB | IC50 | = | 73 | uM | ALA5150238 | 4.14 | nM | |||
10. | ALA2359093 | 2b, RB | IC50 | = | 45 | uM | ALA5150237 | 4.35 | nM | |||
11. | ALA2359093 | 2b, RB | Activity | 0 | ALA4381520 | Active | Homo sapiens | |||||
12. | ALA2359093 | 2b, RB | Activity | 0 | ALA4381519 | Active | Homo sapiens | |||||
13. | ALA2359093 | 2b, RB | Activity | 0 | ALA4381514 | Active | Mus musculus | |||||
14. | ALA2359093 | 2b, RB | Activity | = | 502 | % | ALA4381512 | % | Mus musculus | |||
15. | ALA2359093 | 2b, RB | Activity | 0 | ALA4381508 | Active | ||||||
16. | ALA2359093 | 2b, RB | Activity | = | 69 | % | ALA4381499 | % | Mus musculus | |||
17. | ALA2359093 | 2b, RB | Inhibition | = | 15.27 | % | ALA4303805 | % | Severe acute respiratory syndrome coronavirus 2 | |||
18. | ALA2359093 | 2b, RB | Drug uptake | 0 | ALA4254843 | Active | ||||||
19. | ALA2359093 | 2b, RB | Activity | 0 | ALA4254837 | Dose-dependent effect | Mus musculus | |||||
20. | ALA2359093 | 2b, RB | Activity | 0 | ALA4254836 | Dose-dependent effect | Homo sapiens |